A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King, S; Griffin, S; Hodges, Z; Weatherly, H; Asseburg, C; Richardson, G; Golder, S; Taylor, E; Drummond, M; Riemsma, R

King, S; Griffin, S; Hodges, Z; Weatherly, H; Asseburg, C; Richardson, G; Golder, S; Taylor, E; Drummond, M; Riemsma, R.

Affiliation

King S; Centre for Reviews and Dissemination, University of York, UK.

Health Technol Assess ; 10(23): iii-iv, xiii-146, 2006 Jul.

Article de En | MEDLINE | ID: mdl-16796929

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Propylamines / Trouble déficitaire de l'attention avec hyperactivité / Modèles économiques / Dexamfétamine / Méthylphénidate Type d'étude: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limites: Adolescent / Child / Child, preschool / Humans Langue: En Journal: Health Technol Assess Sujet du journal: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Année: 2006 Type de document: Article Pays d'affiliation: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links